Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.

Archives of pathology & laboratory medicine - 1 Jun 2021

Yao Jinjuan, Arcila Maria E, Ladanyi Marc, Hechtman Jaclyn F

Abstract excerpt

CONTEXT.—: The increasing use of large panel next-generation sequencing technologies in clinical settings has facilitated the identification of pan-cancer biomarkers, which can be diagnostic, prognostic, predictive, or most importantly, actionable. OBJECTIVE.—: To discuss recently approved and emerging pan-cancer and multihistology biomarkers as well as testing methodologies. DATA SOURCES.—: The US Food and Drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Fibroblast Growth Factors
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Microsatellite Instability

Share to Molecular Diagnostic Techniques

Share to Programmed Cell Death 1 Receptor

Share to Receptors, Fibroblast Growth Factor

Source

Identifiers

PMID: 33373449
DOI: 10.5858/arpa.2020-0513-RA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.PMID 33373449Read ↗

Pan-Cancer Molecular Biomarkers: A Paradigm Shift in Diagnostic Pathology.Semantic proximity Read ↗

Pan-Cancer Molecular Biomarkers: A Paradigm Shift in Diagnostic Pathology.Semantic proximity Read ↗

Emerging technologies for improved stratification of cancer patients: a review of opportunities, challenges, and tools.Semantic proximity Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic Profiles.Semantic proximity Read ↗

Special report: multiple molecular testing of cancers to identify targeted therapies.Semantic proximity Read ↗

The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted TherapiesSemantic proximity Read ↗

Moving pan-cancer studies from basic research toward the clinic.Semantic proximity Read ↗

Harnessing tumor-agnostic biomarkers for precision medicine in lymphoma.Semantic proximity Read ↗

Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic.Semantic proximity Read ↗

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.Semantic proximity Read ↗

Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.